Don't wanna be here? Send us removal request.
Text
ASSISTED REPRODUCTIVE TECHNOLOGY MARKET WAS VALUED AT $24.6 BILLION | AT A CAGR OF 10.7%.
The Global Assisted Reproductive Technology Market was valued at $24.6 billion in 2019 and is estimated to surpass $56.3 billion by 2027, at a CAGR of 10.7%. Assisted reproductive technology (ART) is used to treat infertility which includes in vitro fertilization-embryo transfer, zygote intrafallopian transfer, gamete intrafallopian transfer, and frozen embryo transfer.
ART consists of all fertility treatments in which both embryos and eggs are handled. ART procedures mainly involve surgical procedures to remove eggs from a woman’s ovaries (oophorectomy), in-vitro combining them with sperm and returning them to the woman’s body. The extensive growth of the assisted reproductive technology market is majorly attributed to the growing number of infertility cases owing to growing stress, obesity, pollution, and changing lifestyles. In 2020, the global assisted reproductive technology market is projected to observe a massive surge in the global market owing to the presence of established organizations.
The increasing adoption of technological advancements in assisted reproductive technology is projected to foster the demand for assisted reproductive technology, which will ultimately drive the global market, during the forecast period. For instance, in April 2019, Nova IVF Fertility, a significant service provider infertility space, has adopted DNA Fragmentation Index (DFI) testing and Magnetic Activated Cell Sorting (MACS) techniques which are significantly benefiting men with fertility issues in India. The company has achieved around 25,000 clinical pregnancies through in-vitro fertilization (IVF). These technological innovations are expected to accelerate the growth of global assisted reproductive technology, during the analysis period.
Moreover, the extensively increasing prevalence of childlessness, infecundity, and infertility worldwide is one of the major factors driving the demand for assisted reproductive technology in the global market. As per research conducted by CDC (Centers for disease control for prevention) around 12% of women aged 15-44 years in the U.S. have difficulty getting pregnant as well as around 9% of men aged 25-44 years in the U.S. reported that they need doctor’s advice or treatment for infertility. These figures showcase that the global assisted reproductive technology shall have future opportunities in the global market, in the upcoming years.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/covid-19-insights/345/assisted-reproductive-technology-market#download
The unprecedented condition of COVID-19 outbreak across the world has led to the shutdown of business for an uncertain period of time. The industrial processes like production, logistics, and transportation are disrupted due to industrial shutdown, which will ultimately make a negative impact on the global industry. On the other hand, the pandemic spread of COVID-19 has created a positive impact on the global assisted reproductive technology industry. Also, the government authorities are approving assisted reproductive technology for the treatment of infertile couples. For instance, in February 2020, the government of India has passed ‘assisted reproductive technology (ART) regulation bill’ amid the COVID-19 chaos. Moreover, the bill is approved to regulate the ART clinics with an aim to offer ‘safe and ethical’ reproductive procedures to around 27 billion infertile couples of India. Such government supportive policies may offer significant growth for the global assisted reproductive technology market, during the outbreak period.
As per the recent publication of Research Dive, the global assisted reproductive technology market is anticipated to continue it’s substantial market growth in the future years, post the COVID-19 crisis situation settles. The enormously rising adoption of R&D and innovations, increased awareness about assisted reproductive technology, changing lifestyle & habitats, and growing number of patients suffering from infertility and childlessness disorders may offer stimulus to the global assisted reproductive technology market after the end of the COVID-19 outbreak.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
INSURANCE BROKERAGE MARKET WAS VALUED AT $317.9 BILLION IN 2020 AND IS PROJECTED TO REACH $515.3 BILLION BY 2028
The global Insurance Brokerage Market was valued at $317.9 billion in 2020 and is projected to reach $515.3 billion by 2028 registering a CAGR of 5.4%.
Market Synopsis
The rise in demand for insurance policies and several initiatives undertaken by the government in the area of insurance policies are driving the market growth.
However, if the insurance agent or insurance broker is not familiar about the technologies used (for instance, cloud computing and artificial intelligence), it might be difficult for him to assist the client. This might restrain the market growth during the forecast period.
According to the regional analysis of the market, the Asia-Pacific insurance brokerage market is anticipated to grow at a CAGR of 6.5% by generating a revenue of $52.4 billion during the review period.
Insurance Brokerage Market Overview
An insurance broker is a person who works with numerous insurers to sell, request, or negotiate insurance products on behalf of their clients. An insurance broker serves as a link between policyholders and insurers, and thus plays a crucial role in the development of the company’s economy. Insurance brokers provide their clients with technical and expert insurance advice. Health insurance, property and casualty insurance, and medical insurance are among the insurance products offered by brokers. Insurance brokers work closely with their clients to ensure that their coverage needs are met.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/8405
Impact Analysis of COVID-19 on the Global Insurance Brokerage Market
The COVID-19 outbreak has had a negative impact on the growth of the insurance brokerage market. This is due to governments in most nations imposing lockdowns and shutting down businesses, public and private organizations around the world to prevent the virus from spreading. Furthermore, due to the closure of various insurance brokerage firms across developing nations, and shareholders of publicly held insurance brokerage companies withdrawing their contributions from the company to raise funds to meet their daily and conventional needs, the consumer demand for insurance has decreased gradually. Moreover, the shareholders of public trading insurance brokerage companies are withdrawing their contributions in order to raise funds to meet their daily and routine demands. Furthermore, pioneering insurance companies are showing increased interest in insurance brokers in order to improve their business processes and provide immediate insurance services all over the world.
Increasing Technology in the Area of Insurance Brokerage is Anticipated to Drive the Market Growth
Insurance agents and brokers are investing in digital technologies in order to provide assistance online and increasing sales and margins. The process of converting information into digital formats is known as digitalization. This includes providing agents and brokers with knowledge and techniques in digital formats via insurance websites, digital distribution channels, and website interactions. These internet platforms and other mobile applications are intended to improve business processing efficiency and reduce costs. This implementation of technology into the existing services, is said to boost the market growth.
Lack of Knowledge in Insurance Brokers About Technology Used May Restrict the Market Growth
Customers' direct purchases of insurance plans, as well as the availability of multiple platforms for obtaining insurance products, may limit market expansion. For instance, technologies like cloud computing and location analytics provide data about their customers. These technologies provide insurance brokerage firms with extensive data and insights about their clients, allowing them to provide timely, relevant coverage based on individual needs. Lack of knowledge about current technological trends may make it difficult for salespeople, insurance agents, or brokers to market their product to customers.
Government Initiatives in the Field of Insurance Policies is Expected to Increase the Opportunities in the Market
Several government bodies are launching major initiatives in the field of insurance policies, allowing people to access a wide variety of services. Governments are also informing potential customers about the multiple opportunities and risk coverages and assets that can be protected through an insurance scheme. Besides that, the government is putting in place a number of initiatives to support the insurance industry in providing insurance policies to individuals from different walks of life. As a result, these government developments are expected to provide profitable opportunities for the industry in the coming years.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
North America Sports Medicine Market to 2029 - Improving Infrastructure to Support Potential Growth valued at $3,580 million
The North America sports medicine market was valued at $3,580 million in 2018 and is projected to reach $5,382 million by 2025, growing at a CAGR of 6.7% from 2019 to 2025.
The North America Sports Medicine Market is expected to witness significant growth during the forecast period, due to rise in incidence of sports associated injuries, active government participation in encouraging sports activities, and increase in awareness among people regarding physical fitness. In addition, elevation in the demand for minimally invasive surgeries are expected to further supplements the North America sports medicine market growth over the forecast period. However, unfavorable reimbursement strategies, lack of skilled professionals in this field, and inappropriate administration and guidelines regarding sports medicine hamper the growth. Conversely, rising influx of athletes and technological advancements in sports medicine are expected to offer remunerative opportunities for the North America sports medicine market players.
Sports medicine is a field of healthcare, which aids in improving people’s athletic performance. Sport medicine products help people to recover from injuries related to sports & exercise, as well as prevent from future injuries. Before 20th Century, most of the sports teams were used to employ physicians for a team, however, since the late 20th century the sports medicine has emerged as a separate field of health care. In addition, sports medicine has witnessed significant growth among all other healthcare fields, as there are skilled professionals in this field who have the capability to treat all kinds of people, and not just athletes.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/3
In May 2017, Stryker and AlloSource entered into partnership to distribute biologics for sports medicine procedures. The collaboration between Stryker and AlloSource enabled them to combine their unique areas of expertise to develop new ways to improve patient outcomes. The market players have adopted new product launches, product development, product approval, partnerships, agreement, and collaborations as its key business development strategies to guarantee their global dominance in sports medicine market.
The North America sports medicine market is segmented based on product and application. Based on product, it is classified into body reconstruction & repair products, body support & recovery products, body monitoring & evaluation, and accessories. Body reconstruction & repair products are sub-segmented into implants, arthroscopy devices, fracture and ligament repair devices, prosthetic devices, and orthobiologics. Further, body support & recovery products are sub-segmented into thermal therapy products, brace and support devices, and compression clothing. Body monitoring and evaluation is sub-segmented into cardiac monitoring & evaluation, respiratory monitoring & evaluation, hemodynamic monitoring & evaluation, muscoskeletal monitoring & evaluation, and other monitoring & evaluation. Based on application, market is divided into knee injuries, shoulder injuries, ankle & foot injuries, elbow & wrist injuries, hip & groin injuries, back & spine injuries, and other injuries.
Product segment review:
Based on product, the North America sports medicine market is classified into body reconstruction & repair, body support & recovery, body monitoring & evaluation, and accessories. The body reconstruction & repair products segment dominated the North America market in 2018 and is expected to continue this trend throughout the forecast period. This is attributed to maximum revenue generated by use of surgical equipment for the treatment of sports injuries. However, body monitoring & evaluation segment is expected to grow at the fastest pace from 2018 to 2025, owing to shift in preference for the use of latest body monitoring & evaluation devices.
Talk to our Analyst / Ask for a profitable discount and Get More Information: https://www.researchdive.com/3/Analyst-Review/north-america-sports-medicine-market
Application segment review:
Based on application, the North America sports medicine devices market is segmented into hand–wrist injury, shoulder injury, ankle–foot injury, arm–elbow injury, knee injury, back–spine injury, and hip–groin injury. The knee injury segment generated the highest revenue in 2018 and is expected to maintain this dominance throughout the forecast period. This is attributed to the fact that knee injury is considered to be one of the most common injuries that a sportsperson encounters, thus involving large-scale employment of sports medicine devices.
The market is highly competitive in nature, with major players focused on creating awareness regarding the sport medicine industry. Major players in the North America sport medicine market include Smith & Nephew Plc, Stryker Corporation, Johnson & Johnson (Depuy Synthes), Arthrex, Inc., Conmed Corporation (Linvatec Corporation), Zimmer Biomet holdings, Inc., Breg, Inc., Mueller sports medicine, Inc., DJO Global, Inc., and Wright Medical Group N.V.
Key Benefits for North America Sports Medicine Market:
America sport medicine market opportunities. This report provides a detailed quantitative analysis of the current market trends and North America sport medicine market forecast estimations from 2018 to 2025, which assists to identify the prevailing North
A comprehensive analysis of the factors that drive and restrain the growth of the North America sport medicine market is provided.
Country-wise North America sport medicine market conditions are comprehensively analyzed in this report.
The projections in this report are made by analyzing the current North America sport medicine market trends and future market potential from 2018 to 2025 in terms of value.
An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
Key market players within the North America sport medicine market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of market.
North America Sports Medicine Market Segments:
By Product:
· Body Reconstruction and Repair
· Implants
· Arthroscopy Devices
· Fracture and Ligament Repair Devices
· Prosthetic Devices
· Orthobiologics
· Body Support and Recovery
· Thermal Therapy Products
· Brace and Support Devices
· Compression Clothing
· Monitoring Devices
· Others
· Body Monitoring and Evaluation Devices
· Cardiac monitoring and evaluation devices
· Respiratory monitoring and evaluation devices
· Hemodynamic monitoring and evaluation devices
· Muscoskeletal monitoring and evaluation devices
· Other monitoring and evaluation devices
· Accessories
By Application:
· Knee Injuries
· Shoulder Injuries
· Ankle and Foot Injuries
· Back and Spine Injuries
· Elbow and Wrist Injuries
· Hip Injuries
· Other Injuries
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
Sarcopenia Treatment Market Report by Connectivity Technology, by Application, by Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
The Global Sarcopenia Treatment Market size was valued at $ 2742.4 Million in 2018 and is projected to reach $ 3975.0 Million by 2026, registering a CAGR of 4.7% from 2018 to 2026. North America accounted for the highest share in 2018 and is anticipated to maintain its lead in the global Sarcopenia Treatment market throughout the forecast period.
Sarcopenia majorly affects older adults, mainly because ageing disables the ability to produce the proteins required by one’s body to maintain and grow muscles, resulting in functional disability due to decline of muscle structure. This in turn leads to premature mortality, disability as the patients are prone to fractures and worsened quality of life.
Thus, increasing geriatric population is expected to augment sarcopenia treatment market growth. For instance, According to the study published in IntechOpen Journal, 2017, the people aged 60 or over are expected to increase from 841 million to above 2 billion between 2013 and 2050. Thereby equating the geriatric population to 21.1% of the global population.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/24
Moreover, sarcopenia enhances the risk of falls and fractures, as the elderly patients with sarcopenia have muscle loss, decreased strength and function. According to the various studies investigating the association of sarcopenia and falls, published in the Journal of Cachexia, Sarcopenia and Muscle, June 2019, higher risks of falls was reported among sarcopenic individuals compared with non?sarcopenic individuals.
According to the article published by the Conversation Media Group Ltd., sarcopenia affects an estimated 10-30 percent of older adults, varying by age and ethnicity. The condition affects higher percentage of around 40-50 percent for those aged over 80 and living in nursing homes, and up to 75 percent of the older adults in hospital settings. Furthermore, according to the study published in Springer Nature, 2017, the number of patients suffering from sarcopenia is expected to escalate from 10 million in 2016 to around 18 million in 2045, accounting to an overall increase of 72% in Europe.
Key players including GlaxoSmithKline plc, Radius Health Inc., Five Prime Therapeutics, Inc., Abbott Laboratories, Pfizer Inc., Sanofi S.A., Bayer AG, Novartis AG, Cadila Healthcare Ltd, Eli Lilly and Company, Nestlé S.A. and others holds major Sarcopenia Treatment market share.
Increasing research and development activities for development of novel therapies
Increasing investment in research and development to develop effective therapies is expected to augment sarcopenia treatment market growth.
For instance, in March 2018, BIOPHYTIS demonstrated results of Sarconeos (BIO101) for treating sarcopenia, and announced patient enrollment for the SARA-INT international clinical study, at the 8th International Conference on Frailty & Sarcopenia Research (ICFSR).
In December, 2017, AMRA, a company offering body composition analysis services, and Artialis, specialists in musculoskeletal health, collaborated for conducting clinical trials for musculoskeletal disorders, thereby benefiting from AMRA’s technology. The aim of the collaboration is to identify more specific biomarkers for sarcopenia.
Increasing initiatives by government and private organizations
Various public and private organizations are actively involved in developing effective therapies for sarcopenia owing to lack of approved therapies, which is expected to propel market growth.
For instance, in 2016, the Aging in Motion (AIM) Coalition, held an annual meeting with the U.S. Food and Drug Administration (FDA) leaders, scientists, and industry experts to discuss research advances, advance clinical research and make available efficient treatment options for sarcopenia. AIM was initiated by the Alliance for Aging Research, in order to overcome obstacles that hinder the development and evaluation of promising treatments for sarcopenia.
Low awareness
Sarcopenia is a highly prevalent condition in the orthopedic patient population and correlates directly with higher falling rates, fractures, mortality and hospital costs. Lack of awareness in the geriatric population leading to poor disease diagnosis limits treatment adoption, thus hindering sarcopenia treatment market.
Also, sarcopenia is not as widely recognized as a geriatric syndrome compared to dementia or falls and is often not included into routine elderly care as therapies for treating the condition are still underway.
Absence of curative therapy
Currently, no approved muscle building agents for sarcopenia treatment are approved in the U.S., and non-drug therapies such as exercise, physical therapy, lifestyle and diet modification are the only primary methods for treating sarcopenia. Thus, the lack of effective therapies to treat the condition is a major factor creating a negative impact on the market growth.
Key Benefits for Sarcopenia Treatment Market:
This study presents the analytical depiction of the global Sarcopenia Treatment market analysis along with the current trends and future estimations to depict the imminent investment pockets.
The overall Sarcopenia Treatment market opportunity is determined by understanding the profitable trends to gain a stronger foothold.
The report presents information related to the key drivers, restraints, and opportunities of the global Sarcopenia Treatment market with a detailed impact analysis.
The current Sarcopenia Treatment market is quantitatively analyzed from 2018 to 2026 to benchmark the financial competency.
Porter’s five forces analysis illustrates the potency of the buyers and suppliers in the industry.
Sarcopenia Treatment Key Market Segments:
By Treatment Type:
Protein Supplement
Vitamin D and Calcium Supplement
Vitamin B 12 Supplement
By Distribution Channel:
Hospitals
Retail Channels
Online Channels
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
INSURTECH MARKET SIZE IS PREDICTED TO GARNER A REVENUE OF $57,934.0 MILLION IN THE 2021–2028
The global insurtech market size is predicted to garner a revenue of $57,934.0 million in the 2021–2028 timeframe, growing from $7,841.0 million in 2020, at a healthy CAGR of 29.1%.
Market Synopsis
The increasing digitization around the globe and the increasing technological advancements are anticipated to be major contributors of the market.
However, privacy concerns and government regulations are some of the challenges limiting the insurtech market expansion.
According to the regional analysis of the market, the Asia-Pacific insurtech market share is anticipated to grow at a CAGR of 30.2%, by generating a revenue of $13,689.8 million during the review period.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/8506
Insurtech Market Overview
Insurtech refers to the use of technology in the design, distribution, and administration of insurance products and services (Insurance Technology). Insurtech is working on ultra-customized policies, social insurance, and dynamically pricing premiums based on new streams of data from Internet-connected devices. Insurtech helps insurers collect and analyze consumer data that may be used to target the right client at a low cost.
Covid-19 Impact on Insurtech Market
In March 2020, the World Health Organization declared COVID-19 as a pandemic, which resulted in restrictions on travel and disturbances in financial markets, as well as negatively impacted supply chains and production levels. The COVID-19 pandemic has caused massive disruptions and changes in a variety of businesses, as well as a significant rise in the demand for touchless and contactless solutions. Because of their precision and alignment with COVID-19's social distancing standards, insurance technologies are becoming increasingly relevant. Organizations and customers are avoiding physical contact to restrict virus spread. These steps are paving the way for user-friendly insurance technologies like artificial intelligence, blockchain, and others. Moreover, insurtech startups and fintech insurtech companies are gradually increasing among different regions. Therefore, the demand for insurtech solutions has increased significantly during the corona virus pandemic.
Advancements in Technology are Anticipated to Drive the Insurtech Market Growth
Insurance businesses are leveraging innovative digital solutions to extend their operations and establish product lines based on niche client demand as a result of shifting business models, which contributes considerably to market growth. For loss prediction and prevention, risk monitoring, and claims processing, the integration of technologies such as cloud computing, artificial intelligence, and blockchain is becoming a prominent element that is expected to provide profitable potential for insurtech gateway in the coming years.
Security Concerns and Government Regulations Might Restrain the Market Growth
The issue of privacy is one of the most pressing challenges for digitally-based enterprises. Many people are concerned about how their personal data is collected, the extent to which it is used, and whether it is sold solely for commercial advantage. Another source of concern is anti-rebating legislation, which prohibits insurers from providing any services other than insurance. Because certain insurtech apps offer direct robo-advisors or virtual agents, which require separate licensure, this problem is crucial.
Developing Economies are Expected to Create the Opportunities of Insurtech Market
Developing economies provide significant opportunity for insurtech solution providers to grow their products as certain insurers adopt new business models. Furthermore, the need for specialty and customized insurance continues to rise, hastening insurance companies' adoption of insurtech. Insurtech market revenue is expected to rise in the coming years as a result of increased investments in digital transformation, adoption of new technologies such as artificial intelligence, analytics, big data, machine learning, and chatbots, and rapid expansion of domestic business, particularly in countries such as Singapore, Hong Kong, China, and South Korea.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
USED CARS MARKET FORECAST IS PROJECTED TO BE $1,970.0 BILLION IN THE 2021-2028
The global used cars market forecast is projected to be $1,970.0 billion in the 2021-2028 timeframe, growing from $1,179.8 billion in 2020, at a healthy CAGR of 6.8%.
Market Synopsis
The depreciation of new vehicles in terms of resale value after a period of time is a key driving factor that is expected to augment the demand for used cars and increase the growth of the used cars market size.
However, the lack of capital required for maintaining used cars and lack of regulatory measures in the sale and transfer of ownership of the used car are predicted to hamper the market growth.
According to the regional analysis of the market, the Asia-Pacific used cars market share is anticipated to grow at a CAGR of 7.6%, by generating a revenue of $546.7 billion during the forecast period.
Used Cars Overview
The global used cars market comprises passenger cars from different segments such as sedan, SUV, hatch back, and others that operate on fuels such as petrol, diesel, and others. Used cars are sold mainly through two distribution channels: organized (franchise dealers) and unorganized (individual sellers).
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/8497
Covid-19 Impact on Used Cars Market
The Covid-19 impact on used cars market has been moderate. To satiate the ulterior motive of people to buy a car, during the economic recession of the pandemic, they preferred a cheaper option of investing in used cars than shelling out big bucks for brand new cars in markets such as US, UK, China and others. In addition to this, the used car sales have been steadily rising due to a supply and demand imbalance of new cars because of the coronavirus crisis and semiconductor chip shortage that are used in automobiles.
The coronavirus pandemic has enforced the companies in the used cars industry to adopt new methods of operation such as the use of online channels for the sales of used cars and it has positively impacted the used cars market. Carvana’s sales, which sells only used cars online, increased 37% in the year 2020 as compared to 2019, according to CNN. Small online used cars’ sellers such as Vroom.com and Shift.com also saw significant increase in their sales. These factors have positively impacted the global used cars market.
The Depreciation in Resale Value of New Vehicles is a Major Driving Factor That is Expected to Augment the Demand for the Used Cars Market
Depreciation of resale value of new cars is a critical factor in people not opting for new cars. Edmunds.com Inc., an American online resource for automotive inventory and information, stated that the depreciation rate is about 23% in the first year of a purchased car. The low resale value of of a new car definitely affects the consumer's willingness to choose the high value car, which makes the purchase of a used car a more practical solution. As a result, the global acceptance of used cars is increasing and the number of used cars buyers has increased significantly. These factors are expected to aid the growth of used cars market in the forecast period.
The Lack of Financing Facilities for Used Cars to Restrain the Market Growth.
The lack of financing or expensive financing options such as loans from organized sector banks for used cars in many countries are anticipated to hamper the market growth. In addition to this, there is a lack of market standardization in terms of registration of used cars by the independent car dealers and regulatory measures related to operating life of the vehicle for preventing environmental damages such as air pollution in developing and undeveloped countries such as in Africa, which can restrict the market growth in the forecast period.
The Increasing Number of Organized Dealers in Developing Countries is Expected to Create Opportunities for Used Cars Market
The advent of organized players in the market in developing nations is expected to aid the growth of used cars market in the forecast period. With the entry of mainstream original equipment manufacturers (OEMs) in second-hand cars market, consumers can avail certified used cars that assure quality, trust, and better customer experience in the franchise dealerships during the purchase of used cars. Along with credibility, organized players also follow guidelines by the original car manufacturing companies and the government for handling used cars along with prevention of environmental pollution. These are positive used cars market trends and expected to act as facilitators in the growth of the used cars market during the forecast period.
The SUV sub-segment is predicted to have a dominating share in the global market as well as attain the fastest growth and register a revenue of $790.2 billion in 2028, growing from $444.9 billion in 2020 during the forecast period.
The augmenting need for premium vehicles in the developed nations, the growing acceptance for SUV and the increasing disposable income of the population are estimated to propel the growth of the SUV subsegment in the forecast period. As per the International Energy Associations article published in 2019, "Growing preference for SUVs challenges emissions reductions in passenger car market", nearly half of the cars sold in the United States and one-third cars sold in Europe are SUVs. These factors are expected to aid the growth of this subsegment.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
PAYMENT GATEWAY MARKET FORECAST IS ESTIMATED AT $67,434.4 MILLION IN THE 2021–2028
The global payment gateway market forecast is estimated at $67,434.4 million in the 2021–2028 timeframe, growing from $19,250.0 million in 2020 at a healthy CAGR 16.6%.
Payment Gateway Market Insight
Payments are becoming a more common mode of transaction, and online payment platform such as gateways are becoming more crucial. With technological improvements, the payment gateway platform is expected to suffer a further shift in its efficiency, resulting in the imposition of novel alterations. All of this might result in an umpteen of profits for the economy.
The main restraining factor of payment gateway market is rising cyber security issues.
According to the regional analysis of the market, the Asia-Pacific payment gateway market is anticipated to grow at a CAGR of 17.3%, by generating a revenue of $25,652.0 million during the review period.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/8495
Payment Gateway Overview
A payment gateway market is a sort of market that aids in the efficient execution of online transactions between buyers and sellers. It is an ecommerce solution that handles debit and credit card payments by moving sensitive data between payment gateways and front-end processors. As a result, the ecosystem's earnings will be added to the core of e-commerce platforms and jobs. As a result, both new e-commerce platforms' demand for payment gateways and their purchasing power, as well as the general public's masses and trust are expected to rise in the future.
Covid-19 Impact On Payment Gateway Market
COVID-19 has triggered a global public health disaster that has damaged virtually every aspect of people's lives while also placing the global economy on precarious ground. The pandemic and its effects have expedited a number of current trends in consumer and corporate behavior, in the payments sector, as well as bringing new ones, such as supply chain restructuring and cross-border commerce. The payment gateway market has been greatly strengthened in the past year by ongoing movements toward e-commerce, digital payments (including contactless), quick payments, and cash displacement. Amazon, for example, saw 40 % year-over-year growth in the second quarter of 2020, fueled in part by a tripling of grocery sales. Furthermore, differences in purchasing behavior between geographies were greatly decreased, and many consumers, particularly the elderly, began to purchase online for the first time. As a result, electronic peer-to-peer and consumer-to-business payments have increased in popularity. Modern consumers' high expectations compel businesses to offer simpler, faster, and less expensive answers to everyday problems. Furthermore, as the need for cross-border payments grows, businesses must be able to process them swiftly and seamlessly for their customers, which helps to boost the demand for the payment gateway market worldwide.
Increased Ecommerce Sales, as well as Increased Internet Penetration, Projected to Drive the Market Growth
Rising eCommerce sales and improved internet speeds are expected to promote the growth of the payment processing solutions industry. Retail is shifting away from traditional business models due to modern payments, smartphone transactions, and the increased use of online credit card payments. Retailers are putting their efforts on developing innovative mobile payment applications, risk management, and customer service, both online and offline. While certain aspects of this evolution will happen naturally, there will be plenty of opportunities for diverse parties to shape the outcome. The cashless revolution has significant implications for unbanked populations. For example, PayFuture Gateway Platform, a Singapore-based AI-based innovative, has launched a new high-performance payment gateway connector that provides online access to popular local payment options in a variety of emerging markets. With the fast rise of ecommerce around the world, both local and international online merchants may now use Pay Future to join these emerging areas and take advantage of hitherto untapped business prospects. Customers are being prioritized by market participants, who have formed arrangements with credit/debit card companies such as MasterCard, Inc. and Visa, Inc. to simplify the payment process and lower processing rates. Furthermore, the rapidly increasing internet prevalence around the world, developments in mobile payment technology, and an increase in the use of smart phones and mobile wallets for a number of activities are some of the important drivers driving payment gateway market expansion.
Lack of Internet Access in Emerging Countries to Restrain the Market Growth
Internet access in developing countries due to lack of infrastructure and a poor regulatory environment act as a restraining factor. Regardless of the wide internet and mobile penetration across countries such as India, not everyone is able to get seamless and uninterrupted connectivity. Digital payments rely heavily on connection but securing and maintaining reliable internet access across developing countries remain major concerns.
Increasing Demand for Instant Mobile-Based Payments and the Rising Use of Mobile Banking Channels Growth Opportunities
Payment gateway technological improvements have resulted in a broad and developing payment gateway market, as well as a significant growth in the use of BFSI. The sector is expected to rise due to rising demand for rapid mobile payments and increased use of mobile banking channels. Consumers anticipate a flawless user experience in mobile wallets as their tastes shift toward digital payment technology. As a result, the demand for secure and reliable payment gateways to handle the spike in digital payment volumes is rapidly increasing. Furthermore, given the quick speed of innovation in the digital economy, having a solid payment infrastructure is critical for digital commerce enterprises.
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
SYNGAS MARKET SIZE IS ANTICIPATED TO GARNER $64,248.6 MILLION IN THE 2020–2027 PERIOD GROWING FROM $42,100 MILLION
The global syngas market size is anticipated to garner $64,248.6 million in the 2020–2027 period, growing from $42,100 million in 2019 at a noteworthy CAGR of 6.1%.
Market Synopsis
Increasing environmental concerns is one of the key elements for the syngas market growth.
However, significant capital investment required for the syngas manufacturing facilities, may restrict the market growth.
According to the regional analysis of the syngas market, the Asia-Pacific market is expected to surge at a CAGR of 6.2% by generating a revenue of $41,890.1 million throughout the analysis period.
Syngas Overview
Syngas is also known as fuel gas or producer gas which mainly consist of hydrogen (H) and carbon monoxide (CO). Syngas is utilized for the production of methanol which has a crucial role in the manufacturing of acetic acid, formaldehyde, methyl methacrylate, and methyl tertiary-butyl ether. Also, syngas is a prominent platform for the utilization of nonpetroleum carbon resources including shale gas, natural gas, and coal.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/8407
COVID-19 impact on Syngas Market:
The impact of the COVID-19 outbreak has been unprecedented on a global scale. Also, the syngas market has witnessed slow growth throughout the COVID-19 pandemic, mainly due to the obstruction in supply chain, causing delays in the production of syngas. Contrary to this, syngas industry players such as Linde plc, a multinational chemical firm with German-American roots, are coming forward with their effective strategy implementation. For example, in May 2020, Linde plc, announced that it has started up a syngas production plant in Geismar, Louisiana. Such expansions may further drive the market in the coming years.
Growing Adoption of Syngas in the Chemical Sector to Upsurge the Market Growth
Significantly growing demand for syngas from the chemical industries worldwide is one of the crucial factors for the global market growth. Syngas is majorly utilized to produce synthetic natural gas (SNG), which plays a key role in the marine, rail, and road transport industries in the form of compressed natural gas (CNG) and liquefied natural gas (LNG). Also, crucial use of syngas in the fuel gas engines particularly for power supply, improved stability, and low energy cost, may further boost the demand for syngas.
A Higher Initial Investment May Obstruct the Growth of the Global Syngas Market
The main reasons that obstruct the market growth majorly include the significant time required to build the syngas operational plant along with high capital investments. Also, unfavorable conditions raised owing to the COVID-19 crisis are also severely affecting the global syngas industry.
The Robust Presence of Key Players and their Strategic Steps May Create Lucrative Opportunities for the Global Syngas Market in the Future
The syngas industry is projected to grow at a fast pace owing to the presence of prominent players worldwide. The companies such as Linde plc, Air Products and Chemicals, Inc., and Haldor Topsoe A/S have been emphasizing mainly on strategies including acquisitions, expansions, and novel product launches in untapped and potential markets. For instance, in May 2018, BPCL (Bharat Petroleum Corporation Limited), a government-owned oil and gas corporation, and Air Products Inc., American leading industrial gas provider, officially signed a long-term agreement in order to establish, own, and operate a new syngas manufacturing plant. Such key developments are further expected to create investment opportunities for syngas market in the coming years.
The fluidized bed gasifier sub-segment is anticipated to have the largest share in the global market and generate a revenue of $25,721.6 million by 2027.
Fluidized bed gasifier is prominently utilized to enhance turbulence for more complete gasification of low reactivity feedstocks. Also, it has higher cold gas efficiency than entrained-bed gasifiers. Moreover, fluidized bed gasifier is one of the most significant designs for biomass gasification, majorly owing to its applicability to the medium-scale processes. Furthermore, key advantages including high efficiency, flexible feedstock, and lower pollution are expected to drive the demand for fluidized bed gasifiers. Thus, in 2019, the fluidized bed gasifier segment accounted for the highest syngas market share.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
LABORATORY TEMPERATURE CONTROL UNITS MARKET WAS VALUED AT $536.6 MILLION | AT A CAGR OF 5.5%.
The global Laboratory Temperature Control Units Market was valued at $536.6 million in 2019 and is anticipated to surpass $833.8 million by 2027, at a CAGR of 5.5%. The lab temperature control units are mainly utilized in temperature-based measuring, control, monitoring, and safety applications in laboratories and pilot plants.
Laboratory equipment majorly includes temperature-sensitive materials along with imprecise temperature control which can ruin devices, samples, or experiments. Therefore, temperature control units are developed to maintain the desired temperature within environmental chambers, furnaces, or any device prone to temperature swings. The extensive growth of the global market is significantly driven by the increasing emphasis on laboratory safety along with the massive expansion of industries, particularly pharmaceutical and food & beverages. In 2020, the market is projected to witness a considerably positive impact due to the outbreak of coronavirus disease. (COVID-19)
The implementation of supportive government policies about laboratory safety is expected to increase the demand for laboratory temperature controllers, which will ultimately boost the growth of the global laboratory temperature control units market, during the analysis period. Therefore, the leading players across the globe are focusing on innovative product development and their launching. For instance, in November 2019, Briskheat, a global pioneer in temperature-control technology has made an announcement of the launching of the LYNX temperature control system that has the capability to control up to 1,024 zones. Moreover, The LYNX system plays a key role in a wide range of industries, such as laboratory, semiconductor, R&D facilities, cosmetics, pharmaceuticals, petrochemical, composite curing, and process heating and drying. In addition to this, in September 2018, Uniqsis has also launched the Polar Bear Plus GSM—a versatile cooling and heating reactor module for flow chemistry applications. Such factors are expected to increase the growth of the global laboratory temperature control units in the forecast timeframe.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/covid-19-insights/344/laboratory-temperature-control-units-market#download
Moreover, the increasing adoption of laboratory temperature control units in food & beverages and pharmaceutical industries is also estimated to fuel the market growth laboratory temperature control units, during the review period. Also, the pharmaceutical industries are significantly growing across the world. For instance, as per publications of the world industry outlook, the global pharmaceutical industry is expected to register a revenue of $1.2 trillion by 2020, increasing at a growth rate of 4.4%. These figures showcase that the need for laboratory temperature control units will dramatically increase, which may eventually create significant growth opportunities for the global market, throughout the forecast timeframe.
In the last several months of 2019, the outbreak of COVID-19 has created an unprecedented global health emergency. Multiple governments across countries such as India, China, UK have imposed lockdowns in order to curb the community transmission of the coronavirus. Also, the lockdown has led to a tremendous decline in business and industrial operational processes. On the other hand, the organizations operating in laboratory temperature controllers are taking initiatives to fight against the apocalypse of coronavirus. For instance, in April 2020, Peter Huber Kältemaschinenbau AG, German-based temperature controller manufacturers, introduced a high precision ‘temperature control technology’, amid the COVID-19 pandemic. Researchers are mainly using this technology for the manufacturing of coronavirus test reagents. These initiatives may lead to driving the growth of the global market for laboratory temperature control units, during the pandemic period.
Furthermore, many organizations and institutions are coming forward with new innovations to fight the challenges created by the COVID-19 outbreak. For instance, Julabo, a significant leader in temperature control technologies, is developing and shipping temperature controllers to other companies, during the COVID-19 pandemic. These devices help pharmaceutical or biotech organizations to control the temperature of their reactors, which is required for the manufacturing of COVID-19 vaccines. These factors may create huge demand for the laboratory temperature control units, which will ultimately help to generate remarkable revenue for the global market, throughout the COVID-19 outbreak.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
CRITICAL CARE DEVICES MARKET REGISTERED A REVENUE OF NEARLY $32.1 BILLION AND IS ANTICIPATED TO GROW AT 3.2% CAGR
The global Critical Care Devices Market registered a revenue of nearly $32.1 billion in 2019, and is anticipated to grow at 3.2% CAGR, surpassing $41.5 billion by 2027.
The market is going to experience a positive impact in 2020 due to the pandemic. Increasing demand of the critical care devices for treating various chronic diseases is predicted to drive the market in the forecast period. On the other hand, lack of skilled labor is predicted to hinder the market in the forecast period.
Critical care devices are mostly used for treating various chronic diseases. Increasing demand of these devices for treating various deadly diseases like cancer, cardiovascular diseases, respiratory problems and many others is predicted to be the major driving factor for the market in the forecast period. In addition, increasing geriatric population is predicted to be the one of the major reasons for driving the market in the forecast period. Technological advancement in these devices is anticipated to create more investment opportunity in the near future.
Individuals are highly dependent on the critical care health devices that help them to monitor their health. Lack of skilled labor for operating various critical care devices is predicted to hamper the market growth in the forecast period. In addition, critical care health devices cost very high due to which some of the health care institutions cannot afford it, which is predicted to be the biggest restraint for the global critical care market growth in the forecast period.
The critical care devices market will witness to have a positive impact due to the pandemic. It has been noticed that due to the impact of the coronavirus, most of the healthcare institutions have increased the usage of these devices for treating patients, which is predicted to be the biggest driving factor for the market during pandemic. Moreover, increasing demand for intensive care units due to the covid-19 outbreak is predicted to drive the market in the forecast period.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/covid-19-insights/340/global-critical-care-devices-market#download
Governments across the globe have taken various initiative for treating various chronic patients which is predicted to drive the market in the forecast period. For instance, in July 2020 to fight against the corona virus the government of India unveils 3 production incentive schemes worth Rs 12,000 crore to boost local manufacturing of API, medical devices and bulk drugs. The government also notified two other incentive schemes aiming to boost domestic medical manufacturing devices and establishing bulk drugs.
Increasing cases of chronic diseases gives rise to the demand of critical care devices which is predicted to boost the global market in the forecast period. Moreover, increasing cases of transmitted diseases, rise in the geriatric population and road accidents across the globe are predicted to drive the market in the projected period. According to World Health Organization (WHO), it has been estimated that approximately 1.35 million people die each year as a result of road accidents where the emergency care unit are required to provide the patient with necessary medical facilities.
Technological advancement in various critical care devices is predicted to create more investment opportunity for the investors in the forecasted timeframe. For instance, Novalis invests in Enzyre to support development of Enzypad, a breakthrough hand-held diagnostic and monitoring device which helps in monitoring of haemophilia patient blood coagulation status, enabling fast action to prevent or stop bleeding. On the other hand lack of skilled labor and high cost involved in treating patient with various critical care devices is predicted to hamper the market growth in the projected timeframe.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
Neonatal Ventilator Market Registered A Revenue Of Nearly $288.6 Million And Is Anticipated To Grow At A 7.1% CAGR
The global Neonatal Ventilator Market registered a revenue of nearly $288.6 million in 2018 and is anticipated to grow at a 7.1% CAGR, surpassing $474.0 million by 2026.
The market has witnessed a significant growth previously, but due to the unexpected COVID-19 outbreak, the market will witness additional growth in 2020, owing to the increasing demand for neonatal ventilators across the globe. The market might witness a drift in product availability, due to the lack of neonatal ventilators in many countries. Our analysts have estimated the condition of the Neonatal Ventilator Market during the COVID-19 outbreak and have come to the following conclusions.
A ventilator is a medical apparatus that provides mechanical support for patients who are physically unable to breathe or breathing insufficiently. These apparatus provide mechanical assistance in exchange for oxygen and carbon dioxide. Rising deaths among babies, respiratory diseases, and neurological disease will drive the demand of the ventilators in the forecast period. Growing prevalence in smoking, development of healthcare segment, and high healthcare expenditure is expected to drive the market growth. These factors are positively impacting the adoption of neonatal ventilator systems for the treatment of various respiratory diseases, across the globe.
Nonetheless, high cost of neonatal ventilator system is significantly impacting the use of ventilators for treating patients. This factor is majorly restraining the growth of the market. Moreover, improper reimbursement and difficulty coupled with the utilization of ventilators are also considerable factors that are expected to limit the market growth soon.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/covid-19-insights/197/global-neonatal-ventilator-market#download
The global neonatal ventilator market will witness significant growth in 2020 and is anticipated to follow the trend until the end of the forecast period. The rapid growth is majorly attributed to the increasing implementation of ventilators to COVID-19 infected patients, across the globe during this pandemic crisis.
This market is expected to retain its growth even after the control of the pandemic situation. Moreover, according to World Health Organization (WHO), people of age group 40 and above are vulnerable to coronavirus infection and face severe breathing problems which it is foreseen to positively impact on the growth of ventilator market. For instance, several companies are merging their business with ventilator manufacturing company to overcome the lack of ventilators required for treatment of COVID-19 patient.
The COVID-19 pandemic has impacted the neonatal ventilator market positively. As per the World Health Organization (WHO) suggestions, patient suffering from COVID-19 are vulnerable to be associated with breathing problems. This factor is significantly driving the adoption of neonatal ventilator, which will propel the market growth during the COVID-19 outbreak.
Moreover, increasing number of patients, healthcare centers, ICU bed admissions, and coronavirus infected patients is driving the market growth. For instance, COVID-19 pandemic has led to approximately 81k positive cases in China as of March 4, 2020, out of which serious cases require ventilators for treatment, which is positively impacting the market growth during this virus outbreak.
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
Portable Oxygen Kit Market Forecast Will Surpass $2,616.8 Million by 2026 | Increasing From $1,372.6 Million
According to The Portable Oxygen Kit Market analysis by Research Dive, the portable oxygen kit market forecast will surpass $2,616.8 million by 2026, increasing from $1,372.6 million in 2018, at a CAGR of 8.4%. Asia-Pacific market anticipated to reach $ 782.8 Million by 2026. North American market projected to account for $ 1177.6 Million by 2026 during forecast.
The portable oxygen kit is smallest environmentally friendly and refillable equipment. Portable oxygen kit is lightweight, handy and easy to use, that is being used for patients who need additional oxygen. The kit contains portable oxygen cylinder, refilling adopter and regulator.
Driving Factors of Portable Oxygen Kit Industry:
Increasing demand from healthcare and home applications are driving the global portable oxygen kit market
The global portable oxygen kit market is majorly driven by the increase in the occurrence of chronic obstructive pulmonary disease (COPD) coupled with rising number of tobacco smokers across the globe is expected to drive the market growth. Respiratory disease prevalence caused by tobacco smoke is projected to enhance the growth of the portable oxygen kit market in the coming years. Additionally, increasing the number of old age patients who are suffering from respiratory disorders, require need of respiratory support will drive the demand for portable oxygen kit.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/63
Market Restraints:
Oxygen kit price and lack of supply are restraining the growth of portable oxygen kit market
The portable oxygen kit market is restrained by price volatility of oxygen kits and shortage of the portable oxygen kits. Additionally, inappropriate handling of oxygen kits sometimes can cause injuries and fatal are expected to hamper the market growth.
Market Opportunities:
Rising the demands from aerospace and automotive sector will provide significant investment opportunities for the growth of portable oxygen kit market
Increasing the usage of portable oxygen kits in aerospace and automotive sector is projected to drive the growth of the market. This is due to high usage of these kits for disaster prone sites, high speed automotive and battlefield to provide continuous supply of oxygen to the pilots and drivers while driving. Additionally, increase in the number of participants in the adventure sports and portable oxygen kit market development are further expected to enhance the portable oxygen kit market growth.
The global portable oxygen kit market for home applications end use accounted for $535.3 million in 2018, and it is anticipated to experience significant growth over forecast period, due to increase in demands of portable oxygen kits from homes applications. Additionally, growth in the patient recovery and increasing the consumer preference due to its portability is expected to drive the market in the coming years, due to this, the market for home applications end use is anticipated to reach $1,058.8 million by 2026. Healthcare end use held the largest portable oxygen kit market share of 43.0% in 2018, and accounted for $590.2 million in 2018, which is projected to reach $1,125.5 million by 2026, this is due to the high usage in ambulance services and emergency care units in hospitals.
Portable oxygen Kit Market, by Region:
Asia Pacific Portable Oxygen Kit Market Overview 2026:
Asia-Pacific region will have enormous opportunities for the market investors to grow over the coming years
Asia Pacific market projected to account for $782.8 million by 2026, rising from $384.3 million in 2018, with highest CAGR of 9.3%, due to increase in the demands from home application and healthcare end users across the region. Additionally, increasing the air pollution and rise in the number of smokers in Asia-Pacific is further expected to drive the portable oxygen kit market over forecast period.
North America Portable Oxygen Kit Market Overview 2026:
The global market is dominated by North America, which was registered for a highest portable oxygen kit market size and accounted for $617.7 million in 2018. The growth is attributed to rising the occurrence of COPD disease and increase in the number of aged population across the region. The U.S. is major contributor in this region and the market for North America is anticipated to reach $1,177.6 million by 2026.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
Sarcopenia Treatment Market Report by Connectivity Technology, by Application, by Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
The Global Sarcopenia Treatment Market size was valued at $ 2742.4 Million in 2018 and is projected to reach $ 3975.0 Million by 2026, registering a CAGR of 4.7% from 2018 to 2026. North America accounted for the highest share in 2018 and is anticipated to maintain its lead in the global Sarcopenia Treatment market throughout the forecast period.
Sarcopenia majorly affects older adults, mainly because ageing disables the ability to produce the proteins required by one’s body to maintain and grow muscles, resulting in functional disability due to decline of muscle structure. This in turn leads to premature mortality, disability as the patients are prone to fractures and worsened quality of life.
Thus, increasing geriatric population is expected to augment sarcopenia treatment market growth. For instance, According to the study published in IntechOpen Journal, 2017, the people aged 60 or over are expected to increase from 841 million to above 2 billion between 2013 and 2050. Thereby equating the geriatric population to 21.1% of the global population.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/24
Moreover, sarcopenia enhances the risk of falls and fractures, as the elderly patients with sarcopenia have muscle loss, decreased strength and function. According to the various studies investigating the association of sarcopenia and falls, published in the Journal of Cachexia, Sarcopenia and Muscle, June 2019, higher risks of falls was reported among sarcopenic individuals compared with non?sarcopenic individuals.
According to the article published by the Conversation Media Group Ltd., sarcopenia affects an estimated 10-30 percent of older adults, varying by age and ethnicity. The condition affects higher percentage of around 40-50 percent for those aged over 80 and living in nursing homes, and up to 75 percent of the older adults in hospital settings. Furthermore, according to the study published in Springer Nature, 2017, the number of patients suffering from sarcopenia is expected to escalate from 10 million in 2016 to around 18 million in 2045, accounting to an overall increase of 72% in Europe.
Key players including GlaxoSmithKline plc, Radius Health Inc., Five Prime Therapeutics, Inc., Abbott Laboratories, Pfizer Inc., Sanofi S.A., Bayer AG, Novartis AG, Cadila Healthcare Ltd, Eli Lilly and Company, Nestlé S.A. and others holds major Sarcopenia Treatment market share.
Increasing research and development activities for development of novel therapies
Increasing investment in research and development to develop effective therapies is expected to augment sarcopenia treatment market growth.
For instance, in March 2018, BIOPHYTIS demonstrated results of Sarconeos (BIO101) for treating sarcopenia, and announced patient enrollment for the SARA-INT international clinical study, at the 8th International Conference on Frailty & Sarcopenia Research (ICFSR).
In December, 2017, AMRA, a company offering body composition analysis services, and Artialis, specialists in musculoskeletal health, collaborated for conducting clinical trials for musculoskeletal disorders, thereby benefiting from AMRA’s technology. The aim of the collaboration is to identify more specific biomarkers for sarcopenia.
Increasing initiatives by government and private organizations
Various public and private organizations are actively involved in developing effective therapies for sarcopenia owing to lack of approved therapies, which is expected to propel market growth.
For instance, in 2016, the Aging in Motion (AIM) Coalition, held an annual meeting with the U.S. Food and Drug Administration (FDA) leaders, scientists, and industry experts to discuss research advances, advance clinical research and make available efficient treatment options for sarcopenia. AIM was initiated by the Alliance for Aging Research, in order to overcome obstacles that hinder the development and evaluation of promising treatments for sarcopenia.
Low awareness
Sarcopenia is a highly prevalent condition in the orthopedic patient population and correlates directly with higher falling rates, fractures, mortality and hospital costs. Lack of awareness in the geriatric population leading to poor disease diagnosis limits treatment adoption, thus hindering sarcopenia treatment market.
Also, sarcopenia is not as widely recognized as a geriatric syndrome compared to dementia or falls and is often not included into routine elderly care as therapies for treating the condition are still underway.
Absence of curative therapy
Currently, no approved muscle building agents for sarcopenia treatment are approved in the U.S., and non-drug therapies such as exercise, physical therapy, lifestyle and diet modification are the only primary methods for treating sarcopenia. Thus, the lack of effective therapies to treat the condition is a major factor creating a negative impact on the market growth.
Key Benefits for Sarcopenia Treatment Market:
This study presents the analytical depiction of the global Sarcopenia Treatment market analysis along with the current trends and future estimations to depict the imminent investment pockets.
The overall Sarcopenia Treatment market opportunity is determined by understanding the profitable trends to gain a stronger foothold.
The report presents information related to the key drivers, restraints, and opportunities of the global Sarcopenia Treatment market with a detailed impact analysis.
The current Sarcopenia Treatment market is quantitatively analyzed from 2018 to 2026 to benchmark the financial competency.
Porter’s five forces analysis illustrates the potency of the buyers and suppliers in the industry.
Sarcopenia Treatment Key Market Segments:
By Treatment Type:
Protein Supplement
Vitamin D and Calcium Supplement
Vitamin B 12 Supplement
By Distribution Channel:
Hospitals
Retail Channels
Online Channels
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
North America Sports Medicine Market to 2029 - Improving Infrastructure to Support Potential Growth valued at $3,580 million
The North America sports medicine market was valued at $3,580 million in 2018 and is projected to reach $5,382 million by 2025, growing at a CAGR of 6.7% from 2019 to 2025.
The North America Sports Medicine Market is expected to witness significant growth during the forecast period, due to rise in incidence of sports associated injuries, active government participation in encouraging sports activities, and increase in awareness among people regarding physical fitness. In addition, elevation in the demand for minimally invasive surgeries are expected to further supplements the North America sports medicine market growth over the forecast period. However, unfavorable reimbursement strategies, lack of skilled professionals in this field, and inappropriate administration and guidelines regarding sports medicine hamper the growth. Conversely, rising influx of athletes and technological advancements in sports medicine are expected to offer remunerative opportunities for the North America sports medicine market players.
Sports medicine is a field of healthcare, which aids in improving people’s athletic performance. Sport medicine products help people to recover from injuries related to sports & exercise, as well as prevent from future injuries. Before 20th Century, most of the sports teams were used to employ physicians for a team, however, since the late 20th century the sports medicine has emerged as a separate field of health care. In addition, sports medicine has witnessed significant growth among all other healthcare fields, as there are skilled professionals in this field who have the capability to treat all kinds of people, and not just athletes.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/download-sample/3
In May 2017, Stryker and AlloSource entered into partnership to distribute biologics for sports medicine procedures. The collaboration between Stryker and AlloSource enabled them to combine their unique areas of expertise to develop new ways to improve patient outcomes. The market players have adopted new product launches, product development, product approval, partnerships, agreement, and collaborations as its key business development strategies to guarantee their global dominance in sports medicine market.
The North America sports medicine market is segmented based on product and application. Based on product, it is classified into body reconstruction & repair products, body support & recovery products, body monitoring & evaluation, and accessories. Body reconstruction & repair products are sub-segmented into implants, arthroscopy devices, fracture and ligament repair devices, prosthetic devices, and orthobiologics. Further, body support & recovery products are sub-segmented into thermal therapy products, brace and support devices, and compression clothing. Body monitoring and evaluation is sub-segmented into cardiac monitoring & evaluation, respiratory monitoring & evaluation, hemodynamic monitoring & evaluation, muscoskeletal monitoring & evaluation, and other monitoring & evaluation. Based on application, market is divided into knee injuries, shoulder injuries, ankle & foot injuries, elbow & wrist injuries, hip & groin injuries, back & spine injuries, and other injuries.
Product segment review:
Based on product, the North America sports medicine market is classified into body reconstruction & repair, body support & recovery, body monitoring & evaluation, and accessories. The body reconstruction & repair products segment dominated the North America market in 2018 and is expected to continue this trend throughout the forecast period. This is attributed to maximum revenue generated by use of surgical equipment for the treatment of sports injuries. However, body monitoring & evaluation segment is expected to grow at the fastest pace from 2018 to 2025, owing to shift in preference for the use of latest body monitoring & evaluation devices.
Talk to our Analyst / Ask for a profitable discount and Get More Information: https://www.researchdive.com/3/Analyst-Review/north-america-sports-medicine-market
Application segment review:
Based on application, the North America sports medicine devices market is segmented into hand–wrist injury, shoulder injury, ankle–foot injury, arm–elbow injury, knee injury, back–spine injury, and hip–groin injury. The knee injury segment generated the highest revenue in 2018 and is expected to maintain this dominance throughout the forecast period. This is attributed to the fact that knee injury is considered to be one of the most common injuries that a sportsperson encounters, thus involving large-scale employment of sports medicine devices.
The market is highly competitive in nature, with major players focused on creating awareness regarding the sport medicine industry. Major players in the North America sport medicine market include Smith & Nephew Plc, Stryker Corporation, Johnson & Johnson (Depuy Synthes), Arthrex, Inc., Conmed Corporation (Linvatec Corporation), Zimmer Biomet holdings, Inc., Breg, Inc., Mueller sports medicine, Inc., DJO Global, Inc., and Wright Medical Group N.V.
Key Benefits for North America Sports Medicine Market:
America sport medicine market opportunities. This report provides a detailed quantitative analysis of the current market trends and North America sport medicine market forecast estimations from 2018 to 2025, which assists to identify the prevailing North
A comprehensive analysis of the factors that drive and restrain the growth of the North America sport medicine market is provided.
Country-wise North America sport medicine market conditions are comprehensively analyzed in this report.
The projections in this report are made by analyzing the current North America sport medicine market trends and future market potential from 2018 to 2025 in terms of value.
An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
Key market players within the North America sport medicine market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of market.
North America Sports Medicine Market Segments:
By Product:
· Body Reconstruction and Repair
· Implants
· Arthroscopy Devices
· Fracture and Ligament Repair Devices
· Prosthetic Devices
· Orthobiologics
· Body Support and Recovery
· Thermal Therapy Products
· Brace and Support Devices
· Compression Clothing
· Monitoring Devices
· Others
· Body Monitoring and Evaluation Devices
· Cardiac monitoring and evaluation devices
· Respiratory monitoring and evaluation devices
· Hemodynamic monitoring and evaluation devices
· Muscoskeletal monitoring and evaluation devices
· Other monitoring and evaluation devices
· Accessories
By Application:
· Knee Injuries
· Shoulder Injuries
· Ankle and Foot Injuries
· Back and Spine Injuries
· Elbow and Wrist Injuries
· Hip Injuries
· Other Injuries
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
0 notes
Text
Eco-Friendly Packaging Market Report by Connectivity Technology, by Application, by Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
The Global Eco-Friendly Packaging Market registered a revenue of nearly $163.5 billion in 2018 and is anticipated to grow at a 5.3% CAGR, surpassing $248.7 billion by 2026.
Eco-friendly food packaging materials are made up of reusable, non-toxic, recyclable, and biodegradable materials that are made from recycled products. These packaging materials are helpful due to their non-reactivity with the packed products. Shift in the consumer preferences towards eco-friendly and recyclable materials, enhance the demand for food packaging segment. The growth is attributed to the various properties such as non-reactivity, reusability, and non-toxicity of these materials. These factors are positively impacting the adoption of eco-friendly food packaging, across the globe.
The market has witnessed a significant growth previously, but due to the unexpected COVID-19 outbreak, the market will witness a decreased growth rate in 2020, owing to the shut-down of many restaurants, prohibition on transportation, and imposition of several strict rules and regulations taken up by the government. This reduction will be majorly hampered due to the decreased availability of raw materials owing to strict prohibition on transportation. Our analysts have estimated the condition of the eco-friendly food packaging market during the COVID-19 outbreak and have come to the following conclusions.
Ask for a Holistic Sample PDF Copy with Figures, Graphs and Toc’s: https://www.researchdive.com/covid-19-insights/209/eco-friendly-food-packaging-market
KEY ASPECTS OF THE INDUSTRY
However, availability of cheaper products and various engineering problems related with the manufacturing of eco-friendly food packaging materials are the factors restraining the market growth. In addition, risk of contamination due to disposing of non-biodegradable products owing to difficulties faced during the differentiation of non-degradable and degradable and degradable products among people is significantly impacting the usage and recycling of food packaging materials. Moreover, requirement of costly equipment for recycling of food packaging products is also a considerable factor that is expected to limit the market growth in the near future.
The COVID-19 pandemic has impacted the eco-friendly food packaging market negatively. Recycling process of packaging materials involves complex mechanism and costly equipment for both processing and recycling of these materials. Besides eco-friendly food packaging materials are manufactured by using soybeans or corns, and hence there is risk of contamination owing to the pesticides sprayed on these crops. Adding to this, these packaging materials may produce methane when they are buried in the landfills. This methane is more hazardous than carbon dioxide and can absorb heat rapidly that can lead to climate change. These factors are responsible for hampering the market growth in the forecast period of time.
However, some companies are managing this crisis through several other ways to sustain. For example, company named as Nulogy located in Canada has extended its cloud-based technology platform; this technology is utilized for thermal screening of employees and can detect body temperature. This extension of platform has benefited the company by tracing employees in real-time so that they can continue their production with employee safety. On the other hand, government is also providing funds for various manufacturers to sustain in this tough situation.
About Us
Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free: +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
1 note
·
View note